Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33146684.
- Also identified by DOI 10.1001/jamapsychiatry.2020.3567 and PMC identifier 9429743.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines whether consumption of a high-cannabidiol product resulted in detectable amounts of Δ9-tetrahydrocannabinol metabolites in the urine samples of participants.
Medical subject headings
- Cannabidiol
- Cannabinoid Receptor Agonists
- Dronabinol
- Substance Abuse Detection
- Urinalysis